Development, Validity and Reliability Study of the Health Belief Model Scale Regarding Disability and Abilities in Vestibular Migraine Patients
Abstract
Vestibular migraine (VM) is a neurological condition characterized by recurrent episodes of dizziness, imbalance, and migraine-related symptoms. Individuals' responses to health problems are influenced by their health beliefs. The Health Belief Model (HBM) is widely used to evaluate health beliefs, including perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy.
The aim of this study is to develop a Health Belief Model-based scale regarding disability and abilities in patients with vestibular migraine and to evaluate its psychometric properties. During the scale development process, expert opinions from specialists in audiology, psychiatry, neurology, and linguistics will be obtained to assess the content validity of the scale items.
The developed scale will be administered to patients diagnosed with vestibular migraine. In addition, participants in the research group will receive information and awareness training about vestibular migraine in order to increase health belief levels related to disability and abilities. Statistical analyses will be performed to evaluate the psychometric properties of the scale and the applicability of the intervention model.
Conditions: Vestibular Migraine.
Primary outcome: Change in Vestibular Migraine Health Belief Scale Score.
Enrollment: 213 participants.
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 213 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.